Medpace
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.About MEDP
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.
CEOAugust James Troendle
CEOAugust James Troendle
Employees4,500
Employees4,500
HeadquartersCincinnati, Ohio
HeadquartersCincinnati, Ohio
Founded1992
Founded1992
Employees4,500
Employees4,500
MEDP Key Statistics
Market cap6.35B
Market cap6.35B
Price-Earnings ratio31.52
Price-Earnings ratio31.52
Dividend yield—
Dividend yield—
Average volume271.64K
Average volume271.64K
High today$208.24
High today$208.24
Low today$200.51
Low today$200.51
Open price$205.81
Open price$205.81
Volume325.06K
Volume325.06K
52 Week high$235.72
52 Week high$235.72
52 Week low$126.95
52 Week low$126.95
MEDP News
Yahoo Finance 6d
Global Large Molecule Bioanalytical Testing Services Market Report 2022 to 2029: Featuring Charles River, Medpace, WuXi AppTec and Eurofins Scientific Among Others - Yahoo FinanceCompany Logo Dublin, Dec. 01, 2022 (GLOBE NEWSWIRE) -- The "Large Molecule Bioanalytical Testing Services Market Analysis by Phase, by Type, by Test Type, by T...
MEDP Earnings
$0.00
$0.68
$1.37
$2.05
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated— per share
Estimated— per share
ActualExpected Feb 13, After Hours
ActualExpected Feb 13, After Hours